Everolimus and LongActing Octreotide Trial in Polycystic Livers
Status:
Completed
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to reduce polycystic liver volume by treating with octreotide,
whether or not combined with everolimus; to assess whether combination therapy of everolimus
and octreotide gives a bigger reduction of polycystic liver volume than octreotide
monotherapy.